Limitation of antiplatelet therapy after percutaneous coronary intervention.
Nomura
Shosaku
S
Inami
Norihito
N
Kimura
Yutaka
Y
Urase
Fumiaki
F
Maeda
Yasuhiro
Y
Iwasaka
Toshiji
T
D000789:Angina, Unstable / Q000097:blood; D015906:Angioplasty, Balloon, Coronary; D001779:Blood Coagulation Factors / Q000502:physiology; D018946:Chemokine CCL5 / Q000502:physiology*; D019742:Chemokines, CC / Q000502:physiology; D023903:Coronary Restenosis / Q000097:blood / Q000209:etiology*; D006801:Humans; D007962:Leukocytes / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*
D001779:Blood Coagulation Factors; C111792:CCL18 protein, human; C483024:CCL5 protein, human; D018946:Chemokine CCL5; D019742:Chemokines, CC; D010975:Platelet Aggregation Inhibitors; C045071:leukocyte procoagulant activity